CD4 and non-small cell lung carcinoma: It appears that a robust circulating anti-telomerase CD4+ Th1 response plays a strong protective role in NSCLC patients, while high level of exhausted PD-1+/TIM-3+ CD4 T cells in peripheral blood is associated with poor prognosis.